Changes to ACA will affect People with Type 1 Diabetes
The 115th Congress and the Trump Administration has made repealing the Affordable Care Act a top priority. For an estimated 3 million U.S. type 1 diabetes (T1D) and millions of other patients, both children and adults, this would be a devastating blow as protections for those with pre-existing conditions, could disappear.
WE DON’T HAVE MUCH TIME.
DPAC is working with T1DExchange to share stories with Congress about Type 1 diabetes and the impact that proposed changes to the federal healthcare will have on the T1D community.
From T1D Exchange‘s Robin Lord:
T1D Exchange is a patient-centered nonprofit organization that focuses on improving care and accelerating novel diabetes solutions. We see these potential health care changes as a threat to our patient’s ability to receive the best care possible and access lifesaving treatments.
At T1D Exchange, we believe that we can improve quality of life and reduce the burden of managing Type 1 diabetes by investing in new therapeutic innovations. We use our collective medical and scientific resources to support our T1D community in several ways including: patient and caregiver engagement, representing the T1D population through educational and advocacy activities, and leveraging our data and clinical evidence to support regulatory and reimbursement challenges.
The coverage of pre-existing conditions under the ACA/aka Obamacare has benefitted not only those in the individual insurance market but also those of us who are fortunate enough to have employer-sponsored coverage…no more waiting period to have our pre-existing condition covered.
– A Glu community participant
What YOU Can Do Right Now to Help
DPAC and T1DExchange a asking the Type 1 Diabetes community to share their stories and experiences with Congress right now.
We must tell Congress that in order to repeal the Affordable Care Act they must ensure those with pre-existing conditions have continuing protections. Without it, federal health care costs could increase due to complications or lack of access to quality medications, devices, and services.